Institut Carnot Curie Cancer

From therapeutic target to clinical validation

Institut Carnot Curie Cancer offers to industrial partners the possibility of settting-up research collaborations to go from the identification of a therapeutic target to the clinical validation of a drug. For Institut Curie, the Carnot label is a token of:

• Expertise
  Institut Curie must maintain world-class expertise in the field of oncology. The Carnot initiative makes it possible to gather the critical mass needed to create leverage and drivethis state-of-the-art research dynamic.

• Collaborations
  Institut Curie must position itself to focus on the exchange of expertise and know-how. The Carnot initiative allows for transverse projects that encourage this.

Sourcing innovative projects

The Carnot initiative makes possible the support of innovative projects that otherwise would have not been funded. The data collected reduce investment risks of others funding sources that would take in charge the next steps of the most promising opportunities. In France, the Carnot institutes network represents 50% of the national activity in partnership research and now gather more than 13.000 researchers together